Literature DB >> 7639067

Sympathetic skin responses (SSRs) in monofocal brain lesions: topographical aspects of central sympathetic pathways.

D Linden1, P Berlit.   

Abstract

Lesions of the central sympathetic pathways are likely to be of clinical relevance. In patients with acute stroke, in particular, they may be responsible for the partially deleterious cardiac arrhythmia. There is little knowledge of the central organization of sympathetic pathways above the brainstem level for both cardio-efferent and sudomotor fibers. We studied the sympathetic skin response (SSR) in 29 patients with brainstem stroke or infarction in the territory of the middle cerebral artery (MCA) in order to evaluate the pathways mediating emotional sweating. In 24 patients (82.8%) the SSR was pathological. These abnormalities were bilateral with no clear asymmetry in 10 patients (34.5%), bilateral with marked contralateral pathology in 8 patients (27.6%), purely contralateral in 5 patients (17.2%) and purely ipsilateral in one patient (3.5%). Bilateral abnormalities were more frequent and more marked in brainstem than in MCA stroke. This is probably indicative of a more generalized sympathetic dysfunction. In contrast, contralateral abnormalities were more pronounced in MCA than in brainstem infarcts. Our results show that sympathetic skin responses are suppressed in the majority of stroke patients. Asymmetric responses may indicate that sudomotor fibers mediating emotional sweating have their origin or receive input from the contralateral MCA territory.

Entities:  

Mesh:

Year:  1995        PMID: 7639067     DOI: 10.1111/j.1600-0404.1995.tb07023.x

Source DB:  PubMed          Journal:  Acta Neurol Scand        ISSN: 0001-6314            Impact factor:   3.209


  10 in total

Review 1.  Autonomic nervous system disorders in stroke.

Authors:  J T Korpelainen; K A Sotaniemi; V V Myllylä
Journal:  Clin Auton Res       Date:  1999-12       Impact factor: 4.435

2.  Suppressed sympathetic skin response in Parkinson disease.

Authors:  T H Haapaniemi; J T Korpelainen; U Tolonen; K Suominen; K A Sotaniemi; V V Myllylä
Journal:  Clin Auton Res       Date:  2000-12       Impact factor: 4.435

3.  Amplitude loss of electrically and magnetically evoked sympathetic skin responses in early stages of type 1 (insulin-dependent) diabetes mellitus without signs of dysautonomia.

Authors:  L Sagliocco; F Sartucci; O Giampietro; L Murri
Journal:  Clin Auton Res       Date:  1999-02       Impact factor: 4.435

4.  Role of sympathetic nervous system in activity-induced cerebral perfusion.

Authors:  Janne Gierthmühlen; Arne Allardt; Michael Sawade; Gunnar Wasner; Ralf Baron
Journal:  J Neurol       Date:  2010-06-15       Impact factor: 4.849

5.  Electrodermal activity in patients with Parkinson's disease.

Authors:  F Esen; G Celebi; C Ertekin; Z Colakoglu
Journal:  Clin Auton Res       Date:  1997-02       Impact factor: 4.435

Review 6.  Sweat testing to evaluate autonomic function.

Authors:  Ben M W Illigens; Christopher H Gibbons
Journal:  Clin Auton Res       Date:  2008-11-06       Impact factor: 4.435

7.  Disorders of the Autonomic Nervous System after Hemispheric Cerebrovascular Disorders: An Update.

Authors:  Zaid A Al-Qudah; Hussam A Yacoub; Nizar Souayah
Journal:  J Vasc Interv Neurol       Date:  2015-10

8.  Does Virtual Reality-based Kinect Dance Training Paradigm Improve Autonomic Nervous System Modulation in Individuals with Chronic Stroke?

Authors:  Luciana Maria Malosá Sampaio; Savitha Subramaniam; Ross Arena; Tanvi Bhatt
Journal:  J Vasc Interv Neurol       Date:  2016-10

9.  Inclusion of Height and Limb Length when Interpreting Sympathetic Skin Response.

Authors:  Mohamadreza Emad; Sharareh Roshanzamir; Alireza Dabbaghmanesh; Mohsen Zafar Ghasempoor; Heidar Eivazlou
Journal:  Iran J Med Sci       Date:  2016-01

10.  Influence of cerebellar stereotactic stimulation on left-right electrodermal information transference in a patient with cerebral palsy.

Authors:  Petr Bob; Tomas Galanda; Peter Jombik; Jiri Raboch; Miroslav Galanda
Journal:  Neuropsychiatr Dis Treat       Date:  2013-11-29       Impact factor: 2.570

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.